vs

Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and CURTISS WRIGHT CORP (CW). Click either name above to swap in a different company.

CURTISS WRIGHT CORP is the larger business by last-quarter revenue ($947.0M vs $821.5M, roughly 1.2× Acadia Healthcare Company, Inc.). CURTISS WRIGHT CORP runs the higher net margin — 14.5% vs -143.3%, a 157.8% gap on every dollar of revenue. On growth, CURTISS WRIGHT CORP posted the faster year-over-year revenue change (14.9% vs 6.1%). CURTISS WRIGHT CORP produced more free cash flow last quarter ($315.1M vs $-179.5M). Over the past eight quarters, CURTISS WRIGHT CORP's revenue compounded faster (15.2% CAGR vs 3.4%).

Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.

The Curtiss-Wright Corporation is an American manufacturer and services provider headquartered in Davidson, North Carolina, with factories and operations in and outside the United States. Created in 1929 from the consolidation of Curtiss, Wright, and various supplier companies, the company was immediately the country's largest aviation firm and built more than 142,000 aircraft engines for the U.S. military during World War II.

ACHC vs CW — Head-to-Head

Bigger by revenue
CW
CW
1.2× larger
CW
$947.0M
$821.5M
ACHC
Growing faster (revenue YoY)
CW
CW
+8.8% gap
CW
14.9%
6.1%
ACHC
Higher net margin
CW
CW
157.8% more per $
CW
14.5%
-143.3%
ACHC
More free cash flow
CW
CW
$494.6M more FCF
CW
$315.1M
$-179.5M
ACHC
Faster 2-yr revenue CAGR
CW
CW
Annualised
CW
15.2%
3.4%
ACHC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACHC
ACHC
CW
CW
Revenue
$821.5M
$947.0M
Net Profit
$-1.2B
$137.0M
Gross Margin
37.5%
Operating Margin
-142.4%
19.2%
Net Margin
-143.3%
14.5%
Revenue YoY
6.1%
14.9%
Net Profit YoY
-3710.4%
16.2%
EPS (diluted)
$-12.98
$3.69

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACHC
ACHC
CW
CW
Q4 25
$821.5M
$947.0M
Q3 25
$851.6M
$869.2M
Q2 25
$869.2M
$876.6M
Q1 25
$770.5M
$805.6M
Q4 24
$774.2M
$824.3M
Q3 24
$815.6M
$798.9M
Q2 24
$796.0M
$784.8M
Q1 24
$768.1M
$713.2M
Net Profit
ACHC
ACHC
CW
CW
Q4 25
$-1.2B
$137.0M
Q3 25
$36.2M
$124.8M
Q2 25
$30.1M
$121.1M
Q1 25
$8.4M
$101.3M
Q4 24
$32.6M
$117.9M
Q3 24
$68.1M
$111.2M
Q2 24
$78.5M
$99.5M
Q1 24
$76.4M
$76.5M
Gross Margin
ACHC
ACHC
CW
CW
Q4 25
37.5%
Q3 25
37.7%
Q2 25
37.2%
Q1 25
36.3%
Q4 24
38.5%
Q3 24
37.3%
Q2 24
36.2%
Q1 24
35.6%
Operating Margin
ACHC
ACHC
CW
CW
Q4 25
-142.4%
19.2%
Q3 25
4.7%
19.1%
Q2 25
5.8%
17.8%
Q1 25
1.7%
16.0%
Q4 24
4.9%
18.8%
Q3 24
12.1%
18.1%
Q2 24
13.4%
16.4%
Q1 24
12.9%
14.0%
Net Margin
ACHC
ACHC
CW
CW
Q4 25
-143.3%
14.5%
Q3 25
4.3%
14.4%
Q2 25
3.5%
13.8%
Q1 25
1.1%
12.6%
Q4 24
4.2%
14.3%
Q3 24
8.4%
13.9%
Q2 24
9.9%
12.7%
Q1 24
9.9%
10.7%
EPS (diluted)
ACHC
ACHC
CW
CW
Q4 25
$-12.98
$3.69
Q3 25
$0.40
$3.31
Q2 25
$0.33
$3.19
Q1 25
$0.09
$2.68
Q4 24
$0.36
$3.09
Q3 24
$0.74
$2.89
Q2 24
$0.85
$2.58
Q1 24
$0.83
$1.99

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACHC
ACHC
CW
CW
Cash + ST InvestmentsLiquidity on hand
$133.2M
Total DebtLower is stronger
$2.5B
$957.9M
Stockholders' EquityBook value
$1.9B
$2.5B
Total Assets
$5.5B
$5.2B
Debt / EquityLower = less leverage
1.28×
0.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACHC
ACHC
CW
CW
Q4 25
$133.2M
Q3 25
$118.7M
Q2 25
$131.4M
Q1 25
$91.2M
$226.5M
Q4 24
$76.3M
$385.0M
Q3 24
$82.1M
Q2 24
$77.2M
Q1 24
$77.3M
$338.0M
Total Debt
ACHC
ACHC
CW
CW
Q4 25
$2.5B
$957.9M
Q3 25
$2.3B
$968.6M
Q2 25
$2.3B
$958.4M
Q1 25
$2.2B
$958.6M
Q4 24
$2.0B
$1.0B
Q3 24
$1.9B
$1.0B
Q2 24
$1.8B
$1.0B
Q1 24
$1.9B
$1.1B
Stockholders' Equity
ACHC
ACHC
CW
CW
Q4 25
$1.9B
$2.5B
Q3 25
$3.1B
$2.5B
Q2 25
$3.1B
$2.7B
Q1 25
$3.0B
$2.6B
Q4 24
$3.1B
$2.4B
Q3 24
$3.0B
$2.5B
Q2 24
$3.0B
$2.5B
Q1 24
$2.9B
$2.4B
Total Assets
ACHC
ACHC
CW
CW
Q4 25
$5.5B
$5.2B
Q3 25
$6.4B
$5.1B
Q2 25
$6.3B
$5.2B
Q1 25
$6.1B
$5.0B
Q4 24
$6.0B
$5.0B
Q3 24
$5.9B
$4.9B
Q2 24
$5.7B
$4.7B
Q1 24
$5.5B
$4.6B
Debt / Equity
ACHC
ACHC
CW
CW
Q4 25
1.28×
0.38×
Q3 25
0.74×
0.38×
Q2 25
0.74×
0.35×
Q1 25
0.72×
0.37×
Q4 24
0.64×
0.43×
Q3 24
0.62×
0.42×
Q2 24
0.62×
0.43×
Q1 24
0.65×
0.44×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACHC
ACHC
CW
CW
Operating Cash FlowLast quarter
$-86.3M
$352.7M
Free Cash FlowOCF − Capex
$-179.5M
$315.1M
FCF MarginFCF / Revenue
-21.8%
33.3%
Capex IntensityCapex / Revenue
11.3%
4.0%
Cash ConversionOCF / Net Profit
2.57×
TTM Free Cash FlowTrailing 4 quarters
$-439.9M
$553.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACHC
ACHC
CW
CW
Q4 25
$-86.3M
$352.7M
Q3 25
$73.2M
$192.8M
Q2 25
$133.5M
$136.6M
Q1 25
$11.5M
$-38.8M
Q4 24
$116.7M
$301.3M
Q3 24
$163.1M
$177.3M
Q2 24
$171.1M
$111.3M
Q1 24
$-321.3M
$-45.6M
Free Cash Flow
ACHC
ACHC
CW
CW
Q4 25
$-179.5M
$315.1M
Q3 25
$-63.0M
$175.9M
Q2 25
$-34.2M
$117.2M
Q1 25
$-163.2M
$-54.5M
Q4 24
$-86.8M
$278.0M
Q3 24
$-27.1M
$162.7M
Q2 24
$16.9M
$100.3M
Q1 24
$-463.7M
$-57.7M
FCF Margin
ACHC
ACHC
CW
CW
Q4 25
-21.8%
33.3%
Q3 25
-7.4%
20.2%
Q2 25
-3.9%
13.4%
Q1 25
-21.2%
-6.8%
Q4 24
-11.2%
33.7%
Q3 24
-3.3%
20.4%
Q2 24
2.1%
12.8%
Q1 24
-60.4%
-8.1%
Capex Intensity
ACHC
ACHC
CW
CW
Q4 25
11.3%
4.0%
Q3 25
16.0%
1.9%
Q2 25
19.3%
2.2%
Q1 25
22.7%
2.0%
Q4 24
26.3%
2.8%
Q3 24
23.3%
1.8%
Q2 24
19.4%
1.4%
Q1 24
18.5%
1.7%
Cash Conversion
ACHC
ACHC
CW
CW
Q4 25
2.57×
Q3 25
2.02×
1.54×
Q2 25
4.43×
1.13×
Q1 25
1.37×
-0.38×
Q4 24
3.58×
2.56×
Q3 24
2.39×
1.59×
Q2 24
2.18×
1.12×
Q1 24
-4.21×
-0.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACHC
ACHC

Acute Inpatient Psychiatric Facilities$451.2M55%
Comprehensive Treatment Centers$144.2M18%
Medicare$113.7M14%
Residential Treatment Centers$89.7M11%
Self Payor$16.1M2%
Other Payor$10.7M1%

CW
CW

Naval Power$417.4M44%
Defense Electronics$268.3M28%
Aerospace Industrial$262.4M28%

Related Comparisons